India to Kenya: Vinblastine Export Trade Route

The India to Kenya Vinblastine corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $21.9K USD. The route is dominated by VIVIORA LIFESCIENCES PRIVATE LIMITED , which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's vinblastine manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $497 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with vinblastine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 20.3%, placing it at rank #13 among India's top vinblastine export destinations globally.

On the import side, key buyers of Indian vinblastine in Kenya include Ethiopian Pharmaceuticals Supply Ag , TO, TO and 12 others. Ethiopian Pharmaceuticals Supply Ag is the single largest importer with 2 shipments valued at $14.1K USD.

India's vinblastine exports to Kenya are driven primarily by a handful of large-scale manufacturers. VIVIORA LIFESCIENCES PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VIVIORA LIFESCIENCES PRIVATE LIMITED , R.S. SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — together account for 83% of total trade value on this route. The average shipment value of $497 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as vinblastine 10mg inj (1 vial) and (harmless medicines for injectableand capsules and tablets)vinblastine sulphate injection 10mg/10ml(1 vial), suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Ethiopian Pharmaceuticals Supply Ag is the largest importer with 2 shipments worth $14.1K USD — representing 65% of all vinblastine imports from India on this route. A total of 15 buyers are active on this corridor.